
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LH(L) | 118 | 59.9% | -6.88 | 1 | 0.9% |
| SIP(L) | 39 | 19.8% | 1.00 | 78 | 70.3% |
| SLP(L) | 19 | 9.6% | 0.56 | 28 | 25.2% |
| CentralBrain-unspecified | 17 | 8.6% | -4.09 | 1 | 0.9% |
| a'L(L) | 2 | 1.0% | 0.58 | 3 | 2.7% |
| SCL(L) | 2 | 1.0% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns LHPV5a5 | % In | CV |
|---|---|---|---|---|---|
| PRW003 (L) | 1 | Glu | 11 | 6.2% | 0.0 |
| LHCENT1 (L) | 1 | GABA | 11 | 6.2% | 0.0 |
| LHPV5g1_a (L) | 2 | ACh | 11 | 6.2% | 0.8 |
| VM3_adPN (L) | 2 | ACh | 9 | 5.1% | 0.3 |
| LHPV12a1 (L) | 1 | GABA | 7 | 3.9% | 0.0 |
| DM2_lPN (L) | 2 | ACh | 7 | 3.9% | 0.7 |
| LHCENT2 (L) | 1 | GABA | 6 | 3.4% | 0.0 |
| DM3_adPN (L) | 1 | ACh | 6 | 3.4% | 0.0 |
| LHAV5b2 (L) | 1 | ACh | 5 | 2.8% | 0.0 |
| PRW003 (R) | 1 | Glu | 5 | 2.8% | 0.0 |
| CRE050 (R) | 1 | Glu | 4 | 2.2% | 0.0 |
| LHPV12a1 (R) | 1 | GABA | 4 | 2.2% | 0.0 |
| LHAV3b8 (L) | 2 | ACh | 4 | 2.2% | 0.0 |
| CB3347 (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| CB2111 (L) | 1 | Glu | 3 | 1.7% | 0.0 |
| DM3_vPN (L) | 1 | GABA | 3 | 1.7% | 0.0 |
| CB2919 (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| LHAV6a8 (L) | 1 | Glu | 3 | 1.7% | 0.0 |
| LHAV4a1_a (L) | 1 | GABA | 3 | 1.7% | 0.0 |
| LHCENT9 (L) | 1 | GABA | 3 | 1.7% | 0.0 |
| LHAD3f1_b (L) | 2 | ACh | 3 | 1.7% | 0.3 |
| LHPD3a4_b (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| LHCENT12b (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| MBON18 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB1629 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB3030 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB3874 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| LHPD2a1 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| LHAV4a1_b (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| LHCENT6 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| DM1_lPN (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| LHPV5a1 (L) | 2 | ACh | 2 | 1.1% | 0.0 |
| CB1296_a (L) | 2 | GABA | 2 | 1.1% | 0.0 |
| LHPV4a10 (L) | 2 | Glu | 2 | 1.1% | 0.0 |
| LHAV3b2_a (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| M_vPNml86 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| CB1570 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SLP103 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| SMP049 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| M_vPNml87 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHPV5c1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SIP027 (R) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHMB1 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| M_lvPNm28 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHPV5a2 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHPV5a3 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB4107 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB1124 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHAV5a4_c (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB4197 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CRE055 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| CB1902 (R) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB1181 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB2589 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| CB2927 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHAV2k1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SMP126 (R) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB2725 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB2463 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| CB1811 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| VA7m_lPN (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHAV3b13 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHPD4d1 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| AVLP317 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| M_vPNml50 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHAV3k1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| VC2_lPN (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.6% | 0.0 |
| DM4_adPN (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| MBON11 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| downstream partner | # | NT | conns LHPV5a5 | % Out | CV |
|---|---|---|---|---|---|
| LHCENT2 (L) | 1 | GABA | 21 | 14.0% | 0.0 |
| SMP443 (L) | 1 | Glu | 11 | 7.3% | 0.0 |
| FB1G (L) | 1 | ACh | 11 | 7.3% | 0.0 |
| SIP087 (L) | 1 | unc | 11 | 7.3% | 0.0 |
| LHAV3m1 (L) | 1 | GABA | 9 | 6.0% | 0.0 |
| CB4198 (L) | 2 | Glu | 8 | 5.3% | 0.0 |
| LHAD3g1 (L) | 2 | Glu | 7 | 4.7% | 0.1 |
| SIP030 (L) | 1 | ACh | 4 | 2.7% | 0.0 |
| CB3147 (L) | 1 | ACh | 4 | 2.7% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 4 | 2.7% | 0.0 |
| SIP015 (L) | 3 | Glu | 4 | 2.7% | 0.4 |
| LHCENT10 (L) | 2 | GABA | 4 | 2.7% | 0.0 |
| SIP029 (L) | 1 | ACh | 3 | 2.0% | 0.0 |
| SLP390 (L) | 1 | ACh | 3 | 2.0% | 0.0 |
| SMP177 (L) | 1 | ACh | 3 | 2.0% | 0.0 |
| CB4197 (L) | 2 | Glu | 3 | 2.0% | 0.3 |
| SIP013 (L) | 2 | Glu | 3 | 2.0% | 0.3 |
| SIP053 (L) | 2 | ACh | 3 | 2.0% | 0.3 |
| LHPV5e1 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| CB1200 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| SMP076 (L) | 1 | GABA | 2 | 1.3% | 0.0 |
| SIP077 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| SMP234 (L) | 1 | Glu | 2 | 1.3% | 0.0 |
| LHCENT1 (L) | 1 | GABA | 2 | 1.3% | 0.0 |
| FB6V (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP396 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.7% | 0.0 |
| SMP125 (R) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP470 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPV5a3 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPV5a1 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB4107 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB2584 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| CB2910 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB3399 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| LHAV1d2 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB3874 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPV5g1_a (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| SIP027 (L) | 1 | GABA | 1 | 0.7% | 0.0 |
| SLP150 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| SMP568_b (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CRE001 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| PRW003 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP279 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| LHPV10d1 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.7% | 0.0 |